Asaf Danziger - 03 Mar 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Executive Officer, Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Asaf Danziger
Issuer symbol
NVCR
Transactions as of
03 Mar 2022
Net transactions value
+$1,085,547
Form type
4
Filing time
07 Mar 2022, 17:22:15 UTC
Previous filing
12 Jan 2022
Next filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $1,085,547 +13,470 $80.59 13,470 03 Mar 2022 Ordinary Shares 13,470 $80.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 13,470 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.